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Mitogen-activated protein kinases (MAPKs) are
key mediators of the T cell receptor (TCR) signals
but their roles in T helper (Th) cell differentiation
are unclear. Here we showed that the MAPK
kinase kinases MEKK2 (encoded by Map3k2)
and MEKK3 (encoded by Map3k3) negatively regu-
lated transforminggrowth factor-b (TGF-b)-mediated
Th cell differentiation. Map3k2/Map3k3Lck-Cre/
mice showed an abnormal accumulation of regula-
tory T (Treg) and Th17 cells in the periphery, consis-
tent with Map3k2/Map3k3Lck-Cre/ naive CD4+
T cells’ differentiation into Treg and Th17 cells
with a higher frequency than wild-type (WT) cells
after TGF-b stimulation in vitro. In addition,
Map3k2/Map3k3Lck-Cre/ mice developed more
severe experimental autoimmune encephalomyelitis.
Map3k2/Map3k3Lck-Cre/ T cells exhibited
impaired phosphorylation of SMAD2 and SMAD3
proteins at their linker regions,which negatively regu-
lated the TGF-b responses in T cells. Thus, the
crosstalk between TCR-induced MAPK and the
TGF-b signaling pathways is important in regulating
Th cell differentiation.
INTRODUCTION
Naive CD4+ T cells must differentiate into distinct helper T (Th)
cell lineages in order to mount appropriate immune responses
against various classes of pathogens and to maintain tolerance
to self-tissues. The differentiation of Th cell lineages, which
include the Th1, Th2, Th17, and regulatory T (Treg) cell lineages,
depends on signals derived from the T cell receptor (TCR) and
the cytokine milieu of the local environment (Murphy and Reiner,
2002;Weaver et al., 2007). Dysregulation of Th cell differentiation
has been associated with either immune deficiency or autoim-
mune disease (Bettelli et al., 2007). TGF-b is a pleiotropic cyto-
kine crucial for many important biological processes includingadaptive immunity (Li and Flavell, 2008; Massague´, 1998). As
a crucial cytokine for T cell-mediated immunity, TGF-b induces
the differentiation and homeostasis of Foxp3+ Treg cells in the
periphery (Chen et al., 2003), mediates the differentiation of
Th17 cells in cooperation with IL-6 (Bettelli et al., 2006; Veldhoen
et al., 2006), and suppresses the differentiation of Th1 and Th2
cell lineages (Gorham et al., 1998; Li and Flavell, 2008). Perturba-
tion of TGF-b signaling specifically in T cells causes severe auto-
immunity associated with excessive Th1 cell responses (Li et al.,
2006; Marie et al., 2006).
TGF-b triggers a canonical signaling pathway through the
TGF-b receptor-mediated phosphorylation of receptor regulated
(R)-SMAD proteins SMAD2 and SMAD3 on conserved serine
residues at their carboxyl (C) terminus (Derynck and Zhang,
2003; Massague´, 1998). Phosphorylated SMAD2 and SMAD3
subsequently bind to SMAD4 and translocate into the nucleus
tomediate the transcription of target genes (Derynck and Zhang,
2003; Massague´, 1998). Many of the key components of this
canonical pathway have been shown to be essential inmediating
the TGF-b-dependent Treg and Th17 cell differentiation (Malho-
tra et al., 2010; Martinez et al., 2009, 2010; Tone et al., 2008).
In addition to the C-terminal phosphorylation, R-SMADs can
also be phosphorylated by mitogen-activated protein kinases
(MAPKs) at a short region (termed linker region) that links
the N-terminal MH1 domain (MAD homology domain) and the
C-terminal MH2 domain, resulting in the suppression of the
TGF-b signaling pathway (Derynck and Zhang, 2003; Kretzsch-
mar et al., 1999; Matsuura et al., 2005; Wrighton et al., 2009).
The linker region phosphorylation of R-SMADs can also be
mediated by other proline-directed kinases, such as CDKs and
GSK3, resulting in either activation or suppression of R-SMAD
activity (Alarco´n et al., 2009; Guo et al., 2008; Millet et al.,
2009; Wrighton et al., 2009). However, the regulation and signif-
icance of R-SMAD linker region phosphorylation in Th cell
differentiation have not been studied.
MAPKs, which include the extracellular signal-regulated
kinases (ERK1 and 2), the p38 (a, b, g, and d), the c-Jun
N-terminal protein kinase (JNK1, 2, and 3), and the ERK5
MAPKs, are important intracellular signaling networks employed
by all eukaryotic cells to transduce a wide spectrum of extracel-
lular signals triggered by growth factors, cytokines, or stress
factors (Dong et al., 2002; Su and Karin, 1996; Weston et al.,Immunity 34, 201–212, February 25, 2011 ª2011 Elsevier Inc. 201
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include a MAPK, a MAPK kinase (MAP2K), and MAP2K kinase
(MAP3K) (Su and Karin, 1996). Previous studies have established
the roles of individual MAPK pathways in T cell development,
activation, and differentiation (Dong et al., 2002; Su et al.,
1994), but the precise molecular mechanisms by which these
MAPK modules function in Th cell differentiation remain unclear,
nor is much known about their roles in either Treg or Th17 cell
differentiation.
Among 19 MAP3Ks in the mammalian genome, MEKK2 and
MEKK3 are two highly conserved members of the MEK kinase
(MEKK) subgroup of the MAP3K superfamily. Transient expres-
sion of either Map3k2 or Map3k3 in vitro leads to their autoacti-
vation and activates all four major MAPKs: ERK1 and ERK2, p38,
JNK, and ERK5 (Cheng et al., 2000; Huang et al., 2004; Yang
et al., 2001; Zhang et al., 2006). Previous biochemical and
genetic studies show that MEKK2 and MEKK3 regulate either
T cell activation or homeostasis, probably through a mechanism
involving downstream MAPK activation (Guo et al., 2002; Wang
et al., 2009). However, because both MEKK2 and MEKK3 are
coexpressed in T cells as well asmany other cell types and share
substrate specificity (Cheng et al., 2000; Wang et al., 2009), they
may have overlapping function(s) in T cells that cannot be
revealed from studying single gene knockout mice.
Here we report that MEKK2 and MEKK3 negatively regulate
TGF-b signaling in Th cell differentiation. Mice with MEKK2 and
MEKK3 double deficiency in T cells had increased numbers of
Treg and Th17 cells in the periphery.Map3k2/Map3k3Lck-Cre/
(see below) naive T cells exhibited increased sensitivity to TGF-b
stimulation in Treg, Th17, and Th1 cell differentiation because of
a defect in ERK1 and ERK2 activation, resulting in hypophos-
phorylation of SMAD2 and SMAD3 at their linker regions.
Map3k2/Map3k3 Lck-Cre/ mice developed more severe EAE
disease and had more antigen-specific Th17 cells that were
preferentially accumulated in the central nervous system.
Together, our study uncovers a T cell-intrinsic regulatory
mechanism for the TGF-b-mediated Th cell differentiation and
demonstrates that T cell sensitivity to TGF-b is dynamically
tuned by the TCR-induced activation of MEKK2 and MEKK3
through phosphorylation of SMAD2 and SMAD3 at their linker
regions.
RESULTS
Generation ofMap3k2–/–Map3k3 Lck-Cre/– Mice
To study the roles ofMEKK2 andMEKK3 in T cells, we generated
MEKK2 and MEKK3 T cell double-deficient mice by crossing the
Lck-Cre;Map3k3fl/ (referred as Map3k3Lck-Cre/) mice with the
Map3k2/mice (Guo et al., 2002; Wang et al., 2009). The result-
ingMap3k2/Map3k3Lck-Cre/mice haveMekk3 deleted specif-
ically in T cells andMekk2 deleted globally, resulting in the loss of
both MEKK2 and MEKK3 only in the T cell lineage (Figure S1A
available online).
Map3k2/Map3k3Lck-Cre/ mice were viable with no obvious
abnormalities in nonimmune tissues (data not shown). The total
number of thymocytes in the Map3k2/Map3k3Lck-Cre/ mice
was similar to that in wild-type (WT)mice, containing all themajor
subsets of thymocytes suggesting that MEKK2 and MEKK3 are
not essential for the thymocyte development (data not shown).202 Immunity 34, 201–212, February 25, 2011 ª2011 Elsevier Inc.Map3k2/Map3k3Lck-Cre/ mice had reduced numbers of
CD4+ and CD8+ T cells in the periphery (data not shown),
consistent with our recent finding that MEKK3 regulates T cell
homeostasis in the periphery (Wang et al., 2009). Despite the
reduction of total spleen cell number, the percentages of CD4+
and CD8+ T cells seemed only slightly reduced in the
Map3k2/Map3k3Lck-Cre/ mice (Figure 1A). However, when
compared to WT mice there was a dramatic increase in the
frequency of Map3k2/Map3k3Lck-Cre/ CD4+ T cells with an
effector or memory-like (CD44hiCD62Llo) phenotype (Figure 1A).
Increased Numbers of Treg and Th17 Cells in the
Periphery ofMap3k2–/–Map3k3Lck-Cre/– Mice
Despite the increased effector or memory-like T cell population
in Map3k2/Map3k3Lck-Cre/ mice, the percentage of Foxp3+
splenic CD4+ cells (Treg cells) was 2-fold higher than in
the WT mice (Figure 1B). However, the absolute number of
Foxp3+ cells in the periphery was not altered substantially
(Figure S1B) because the total splenic CD4+ T cells in
Map3k2/Map3k3Lck-Cre/ mice was only about half of that in
the WT mice (data not shown). The frequency and number of
Foxp3+ Treg cells in the thymus of theMap3k2/Map3k3Lck-Cre/
mice were not altered (data not shown), indicating that the
increased frequency of Treg cells in the periphery of
Map3k2/Map3k3Lck-Cre/ mice was not due to enhanced
thymic production. Deletion of both MEKK2 and MEKK3 was
required for the increased Treg cell percentage because neither
Map3k2/ mice nor Map3k3Lck-Cre/ mice manifested this
defect (Figure 1C). Furthermore, the Treg cells in the
Map3k2/Map3k3Lck-Cre/ mice appeared functional and were
able to suppress naive T cell proliferation in vitro with only
a slightly reduced efficiency compared to their WT counterparts
(Figure S1C).
We next examined the effector T cell subsets in the periphery
of the Map3k2/Map3k3Lck-Cre/ mice. About 4%–5% of the
peripheral Map3k2/Map3k3Lck-Cre/ CD4+ T cells expressed
IL-17A (Th17), whereas less than 0.5% of these cells were found
in WT mice (Figure 1D). The total number of Th17 cells was also
3–4 times more in the Map3k2/Map3k3Lck-Cre/ mice than in
the WT mice (Figure S1B). Again, deletion of both MEKK2
and MEKK3 was required for the increased Th17 cells in
the periphery (Figure 1E). The percentage of interferon-g
(IFN-g)-producing CD4 T (Th1) cells was marginally increased
but the total number of these cells was not increased in the
Map3k2/Map3k3Lck-Cre/ mice (Figure 1D and data not
shown). The IL-4-producing T (Th2) cells were also not markedly
changed in the Map3k2/Map3k3Lck-Cre/ mice (data not
shown). Similar data were obtained from analyzing the lymph
node T cells (data not shown). Together, these results suggest
that deletion of both Map3k2 and Map3k3 in T cells redirects
Th cell differentiation favoring the Treg and Th17 cell lineages.
Because Map3k2/Map3k3Lck-Cre/ mice have increased
frequency of CD62LloCD44hi T cells in the periphery, it is possible
that the increased number of Th17 cells observed in these mice
is simply a consequence of more effector cells in the periphery.
To examine this possibility, we compared the frequencies of
IL17A- and IFN-g-producing T cells within the effector T cells
(CD44hi) between the WT and the Map3k2/Map3k3Lck-Cre/
mice. After normalizing to the CD44hi population, the
Figure 1. Loss of Map3k2 and Map3k3 in T Cells Results in Accumulation of Treg and Th17 Cells In Vivo
(A) Splenocytes from wild-type (WT) andMap3k2/Map3k3Lck-Cre/ (dKO) mice were stained for CD4, CD8, CD44, and CD62L and analyzed by flow cytometry.
The percentages of CD4+ and CD8+ T cells are shown at the upper panels. The gated CD4+ T cells were further analyzed for CD44+ and CD62L+ subpopulations
(lower panels). Numbers in the profiles indicate the percentages of the gated populations.
(B) Splenocyteswere stained for CD4 and Foxp3 to show the percentages (numbers in the gated boxes) of Foxp3+CD4+ T cells (Treg) in the spleen ofWT and dKO
mice. Data shown are from gated splenic CD4+ cells. FSC, forward scatter.
(C) Summary of splenic Foxp3+CD4+ T cells in WT (n = 8), dKO (n = 5),Map3k3Lck-Cre/ (3-cKO) (n = 6), and Map3k2/ (2-KO) mice (n = 6). Error bars show the
standard deviation. **p < 0.01 by two-tailed Student’s t test.
(D) Ex vivo splenocytes were stimulated with PMA+ionomycin for 6 hr and then analyzed for IL-17A- and IFN-g-expressing CD4+ T cells by flow cytometry.
The data shown were gated on CD4+ splenocytes and the percentages of IL-17A- and IFN-g-expressing CD4+ T cells from WT and dKO mice are shown in
the quadrants.
(E) Summary of splenic Th17+ CD4+ T cells in WT (n = 10), dKO (n = 8), 3-cKO (n = 6), and 2-KO (n = 6) mice. Error bars show the standard deviation. **p < 0.01 by
two-tailed Student’s t test.
(F and G) Rag1/mice were reconstituted with mixed bone marrow cells from B6.SJL (CD45.1+) and dKO (CD45.2+) mice, or frommixed B6.SJL (CD45.1+) and
WT (CD45.2+) mice at roughly a 1 to 1 ratio. Total splenocytes in the recipient mice were analyzed 8 weeks later for CD4+Foxp3+ cells (F) or CD4+IL-17A+ cells (G)
as indicated. Data shown are gated on CD4+CD45.1+ (B6.SJL) or CD4+CD45.2+ (WT or dKO) populations. Numbers next to the gated areas show the percentages
of the gated population and the results are representative of six pairs of mice from two independent experiments.
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MAPK Limits TGF-b Responses in Developing Th CellsMap3k2/Map3k3Lck-Cre/ CD4 T cells still had much higher
frequency of Th17 cells than the WT CD4 T cells (8.76% versus
2.26%), whereas the frequency of IFN-g+ cells was indeed lower
in the same subset of Map3k2/Map3k3Lck-Cre/ cells
compared to that of the WT T cells (12.1% versus 21.9%) (Fig-
ure S1D). Thus, the increased frequency of Th17 cells in the
Map3k2/Map3k3Lck-Cre/ mice was probably not caused by
the augmented numbers of CD62LloCD44hi T cells in
Map3k2/Map3k3Lck-Cre/ mice.
To further analyze the effect of MEKK2 and 3 deficiency on
T cell differentiation in vivo, we directly compared the gene
expression profiles of freshly isolated CD4+CD62LloCD44hi cells
between Map3k2/Map3k3Lck-Cre/ and WT mice. By using an
Illumina Microarray (Figure S1E, Table S1) and real-time quanti-
tative RT-PCR (Figure S1E), we found that the expression of
Th17 cell lineage-specific genes (Il17A, Rorc, and Ccr6) was
markedly increased in the Map3k2/Map3k3Lck-Cre/ T cells,
whereas the expression of Th1 cell lineage-specific genes
(Tbx21, Il12rb1, Ifng, Irf1, Fasl, etc.) was suppressed. These
data together suggest that MEKK2 and 3 may inhibit Th17 cell
differentiation while being required for optimal Th1 cell differen-
tiation in the periphery.
MEKK2 and MEKK3 Suppress Treg and Th17 Cell
Differentiation through a Cell-Intrinsic Mechanism
To test whether the defects in Treg and Th17 cell differentia-
tion in the Map3k2/Map3k3Lck-Cre/ mice were intrinsic to
T cells, we reconstituted irradiated Rag1/ mice with
Map3k2/Map3k3Lck-Cre/ (CD45.2+) bone marrow cells mixed
at a 1:1 ratio with WT congenic (CD45.1+) bone marrow cells.
Eight weeks after the reconstitution, we analyzed the pheno-
types of donor T cells in the periphery of the chimeric mice.
The frequencies of the Map3k2/Map3k3Lck-Cre/ Foxp3+ CD4
cells (Figure 1F) and Map3k2/Map3k3Lck-Cre/ IL-17A+ CD4
T cells (Figure 1G) in the spleens were consistently higher than
their WT counterparts derived from the cotransferred congenic
WT bone marrow cells in the same host, resembling the T cell
phenotypes found in the parental Map3k2/Map3k3Lck-Cre/
mice. We also generated bone marrow chimeric mice by trans-
ferring nonmixed control WT bone marrow cells or
Map3k2/Map3k3Lck-Cre/ bone marrow cells into the Rag1/
mice. Again, the peripheral Map3k2/Map3k3Lck-Cre/ T cells
from those chimeric mice also fully recapitulated the phenotypes
of T cells from the parental Map3k2/Map3k3Lck-Cre/ mice,
including the increased activated or memory-like T cells and
increased frequencies of Treg and Th17 cells in the periphery
(Figure S1F). These data together demonstrate that MEKK2
and 3 suppress Treg and Th17 cell lineage differentiation through
a cell-intrinsic mechanism.
Map3k2–/–Map3k3Lck-Cre/– Naive T Cells Are
Hypersensitive to TGF-b-Mediated Differentiation
To determine whether the Treg and Th17 cell phenotypes
in Map3k2/Map3k3Lck-Cre/ mice were caused by defects
in naive T cell differentiation, we examined in vitro differen-
tiation of naive Map3k2/Map3k3Lck-Cre/ CD4 T cells
(CD4+CD62LhiCD44loCD25). Under the Treg cell differentiation
condition, we found that at concentrations of 5 or 1 ng/ml of
TGF-b, 82% or 60.8% of Map3k2/Map3k3Lck-Cre/ naive204 Immunity 34, 201–212, February 25, 2011 ª2011 Elsevier Inc.T cells differentiated into the Foxp3+ Treg (iTreg) cells, respec-
tively; whereas 33.2% or 14.2% of WT T cells differentiated
into iTreg cells, respectively, under the same condition (Fig-
ure 2A). Interestingly, about 30% of Map3k2/Map3k3Lck-Cre/
T cells spontaneously differentiated into iTreg cells without exog-
enous TGF-b whereas almost no WT iTreg cells were generated
under the same condition (Figure 2A). To determine whether the
spontaneous induction ofMap3k2/Map3k3Lck-Cre/ iTreg cells
was caused by the trace amount of TGF-b in the culture medium,
a neutralizing antibody against TGF-b was added into the
culture, which completely eliminated the iTreg cell differentiation
from the Map3k2/Map3k3Lck-Cre/ T cells (Figure 2A).
To determine whetherMap3k2/Map3k3Lck-Cre/ T cells were
the source of TGF-b, WT andMap3k2/Map3k3Lck-Cre/ T cells
werecodifferentiatedunderTregcell conditionat 1:1 ratiowithout
exogenous TGF-b. As shown in Figure 2B, only the
Map3k2/Map3k3Lck-Cre/ T cells but not the cocultured WT
T cells acquired Foxp3 expression indicating that the
Map3k2/Map3k3Lck-Cre/ T cells did not overproduce TGF-b
and the augmentedMap3k2/Map3k3Lck-Cre/ T cell differentia-
tion into iTreg cells was not mediated by an autocrine and/or
paracrine mechanism. Rather, the Map3k2/Map3k3Lck-Cre/
Tcellsbut not theWTTcellswereable to respond to traceamount
of TGF-b presented in the culture medium. Moreover, the in vitro
generated Map3k2/Map3k3Lck-Cre/ iTreg cells were as
suppressive as the WT iTreg cells differentiated under the
same condition (data not shown). Together, these data
indicate that Map3k2/Map3k3Lck-Cre/ T cells are intrinsically
hypersensitive to TGF-b stimulation as measured by iTreg cell
differentiation.
Next, we examined the Th17 cell differentiation from the naive
Map3k2/Map3k3Lck-Cre/ T cells in vitro with TGF-b and IL-6
(Bettelli et al., 2006; Veldhoen et al., 2006). We found that the
Th17 cell differentiation from naive Map3k2/Map3k3Lck-Cre/
T cells was also augmented when compared to WT T cells (Fig-
ure 2C). Similar to the iTreg cell differentiation, differentiation of
Th17 cells from naive Map3k2/Map3k3Lck-Cre/ T cells could
be completely blocked by a TGF-b antibody. We found that
substantial numbers of Map3k2/Map3k3Lck-Cre/ T cells (up
to 9.7%), but not WT T cells, acquired Foxp3 expression by
this Th17 cell differentiation procedure, with some cells coex-
pressing both Foxp3 and IL-17A (Figure 2C). Because strong
TGF-b signal could induce Foxp3 expression under Th17 cell
conditions (Zhou et al., 2008), this further suggests that the
Map3k2/Map3k3Lck-Cre/ T cells were much more sensitive
to TGF-b stimulation than WT T cells. Under the Th17 cell differ-
entiation procedure, the Map3k2/Map3k3Lck-Cre/ T cells also
expressed substantially higher amounts of RORgt than WT
T cells (Figure S2A). Expression of other Th17 cell lineage-
specific genes, such as Il-17f, Il-23r, and Il-21, but not Il-22 or
Il-21r, was also elevated in the Map3k2/Map3k3Lck-Cre/
T cells (Figure S2B). Thus, MEKK2 and MEKK3 negatively regu-
late the TGF-b response in Th17 cell differentiation.
Because TGF-b signaling is also known to inhibit Th1 cell differ-
entiation, the augmented TGF-b responsiveness in Map3k2/
Map3k3Lck-Cre/ T cells would predict an enhanced inhibition
of Th1 cell differentiation by TGF-b. Indeed, by using the Th1
cell differentiation procedure, we observed a much more
sensitive dose response of TGF-b inhibition of IFNg-producing
Figure 2. MEKK2 andMEKK3 Suppress the TGF-b-
Mediated T Cell Differentiation In Vitro
(A) Naive CD4+ T cells (CD4+CD62LhiCD44loCD25) from
WT and Map3k2/Map3k3Lck-Cre/- (dKO) mice were
differentiated into Foxp3+ Treg cells with the indicated
concentrations of TGF-b. Induction of the Foxp3+ cells
was analyzed 5 days after differentiation. When indicated,
a TGF-b antibody (a-TGFb) (5 mg/ml) was added
throughout the culture.
(B) Naive dKO CD4+ T cells (CD45.2+) or WT B6.SJL CD4+
T cells (CD45.1+) were differentiated into Treg cells alone
or in a mixed culture at a 1:1 ratio without exogenous
TGF-b. The frequencies of differentiated Foxp3+ cells
from dKO and B6.SJL CD4+ T cells were determined
5 days later.
(C) Naive CD4+ T cells from either WT or dKO mice were
differentiated into Th17 cells with indicated concentra-
tions of TGF-b and 20 ng/ml IL-6. At day 5, the differenti-
ated cells were washed and restimulated with PMA+-
ionomycin for 4 hr, and the IL17A+ and Foxp3+ cells
were determined by flow cytometry.
(D) Naive CD4+ T cells from either WT or dKO mice were
differentiated into Th1 cells with 10 ng/ml IL-12 plus indi-
cated concentrations of TGF-b. At day 5, the IFN-g+ and
IL-17A+ cells were determined by flow cytometry as in (C).
The numbers in the graphs indicate the percentages of the
gated populations. Data are representative of either three
(A, C, D) or two (B) independent experiments.
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MAPK Limits TGF-b Responses in Developing Th CellsTh1 cell differentiation from Map3k2/Map3k3Lck-Cre/ cells
(Figure 2D). Even a low concentration of TGF-b (e.g., 1 ng/ml)
that had minimal effect on the WT T cells blocked most of Th1
cell differentiation of theMap3k2/Map3k3Lck-Cre/ T cells (Fig-
ure 2D). Furthermore, the induction of T-bet, a key transcription
factor for Th1 cell lineage differentiation and a direct target of
TGF-b (Gorelik et al., 2002), was inhibited more effectively by
TGF-b in the Map3k2/Map3k3Lck-Cre/ T cells than in the
WT T cells (data not shown).Immunity 34, 201Taken together, these data demonstrate
that the Map3k2/Map3k3Lck-Cre/ naive
CD4+ T cells are hypersensitive to TGF-
b-mediated induction of Treg and Th17 cell
differentiation and to TGF-b-mediated inhibition
of Th1 cell differentiation. Consistent with the
in vivo data, the augmented TGF-b sensitivity
in Map3k2/Map3k3Lck-Cre/ T cells in vitro
also required deletion of both Map3k2
and Map3k3 because neither Map3k2/
nor Map3k3Lck-Cre/ naive T cells had
augmented iTreg cell differentiation (Fig-
ure S2C). Moreover, CD4+CD25 SP thymo-
cytes from the Map3k2/Map3k3Lck-Cre/
micewere also hypersensitive to TGF-b stimula-
tion during Th cell differentiation (data not
shown). Additionally, we also examined
Th2 cell differentiation and found that
the Map3k2/Map3k3Lck-Cre/ CD4+ T cells
appeared to have some reduction in the IL-4-
induced Th2 cell differentiation (Figure S2D),
which could be due to the increase of basalTGF-b signals inMap3k2/Map3k3Lck-Cre/ T cells that is known
to inhibit Th2 cell differentiation (Gorelik et al., 2000).
Inhibition of TGF-b Signaling in Map3k2–/–
Map3k3Lck-Cre/– Mice Blocks Treg and Th17 Cell
Differentiation In Vivo
The above results thus suggest that the increased Treg and Th17
cell differentiation in Map3k2/Map3k3Lck-Cre/ mice could be
due to an augmented TGF-b signal in its T cells. To test this–212, February 25, 2011 ª2011 Elsevier Inc. 205
Figure 3. Inhibition of TGF-b Signaling in
theMap3k2–/–Map3k3Lck-Cre/–Mice Reduces
Treg and Th17 Cells in the Periphery
(A) Map3k2/Map3k3Lck-Cre/ (dKO) mice were
treated with TGFbRI inhibitor SB431542 or
DMSO every other day for 10 days. The Foxp3+
CD4+ T cells in the peripheral blood of dKO mice
before the treatment (Day 0) and 10 days after
the treatment (Day 10) were determined. The
numbers next to the gated boxes show the
percentages of the gated populations. Data are
representative of three independent experiments.
(B) Summary of Foxp3+ cells as the percentages of
total CD4+ T cells in the peripheral blood of three
pairs of wild-type (WT) and dKO mice before and
after treatment with SB431542 or DMSO. Each
symbol in the graph represents one individual
mouse.
(C and D) Splenic CD4 T cells from the dKO mice
that were treated with SB431542 or DMSO were
analyzed for the frequency of Foxp3+ population
(C) or IL17A+ population (D) by flow cytometry.
The numbers next to the gated boxes show the
percentages of the gated populations. Data are
representative of five mice per group from two
independent experiments.
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MAPK Limits TGF-b Responses in Developing Th Cellspossibility, we treated the Map3k2/Map3k3Lck-Cre/ mice with
a TGF-b receptor kinase inhibitor SB431542 (Inman et al., 2002).
The inhibitor showed little effect on the ratios of naive versus
effector or memory-like T cells in the periphery of either WT
mice or the Map3k2/Map3k3Lck-Cre/ mice (data not shown).
However, 10 days after the treatment, the frequencies of
Foxp3+ Treg cells in the blood of Map3k2/Map3k3Lck-Cre/
mice were reduced to that in the WT mice (Figures 3A and 3B).
Moreover, the percentages of Foxp3+ Treg cells and Th17 cells
in the spleen of Map3k2/Map3k3Lck-Cre/ mice were also
reduced after the inhibitor treatment (Figures 3C and 3D). As
a control, the inhibitor had only marginal effect on the frequen-
cies of Treg and Th17 cells in WT mice (Figure 3B and data not
shown). These data suggest that the abnormal accumulation of
Treg and Th17 cells in the Map3k2/Map3k3Lck-Cre/ mice
was due to the elevated TGF-b signals in T cells.
MEKK2 and MEKK3 Are Essential for the TCR-Induced
Phosphorylation of R-SMAD at the Linker Region
Despite the antagonism between the Th17 and Treg cell lineage
differentiation (Zhou et al., 2008), our in vivo and in vitro data
indicated that theMap3k2/Map3k3Lck-Cre/ T cells were prone
to both lineage differentiations, suggesting that MEKK2 and 3
may inhibit the TGF-b pathway, which is shared for both Th17
and iTreg cell lineage differentiation. To confirm that the TGF-b
signaling pathway in Map3k2/Map3k3Lck-Cre/ T cells was
indeed hyperactive, we examined the SMAD transcription
activity in the Map3k2/Map3k3Lck-Cre/ T cells with CAGA12-
Luc, a synthetic SMAD-dependent luciferase reporter (Dennler
et al., 1998). As expected, the induction of the reporter activity
in Map3k2/Map3k3Lck-Cre/ T cells was significantly higher
than that in WT T cells (Figure 4A). However, the augmented
SMAD reporter activity in the Map3k2/Map3k3Lck-Cre/206 Immunity 34, 201–212, February 25, 2011 ª2011 Elsevier Inc.T cells was not caused by the enhanced SMAD3 phosphoryla-
tion at theC-terminal-conserved sites at Ser423+425 (Figure 4B),
because such phosphorylation was comparable between the
Map3k2/Map3k3Lck-Cre/ T cells and WT T cells (Figure 4C).
Although TGF-b is known to induce a noncanonical pathway
through MAPK activation (Derynck and Zhang, 2003), we did
not observe substantial induction of ERK1 and 2 or p38 MAPK
activation in response to TGF-b stimulation in either WT or
Map3k2/Map3k3Lck-Cre/ T cells (data not shown).
In addition to the C-terminal phosphorylation, R-SMADs
can also be phosphorylated by MAPKs at the linker region
(Figure 4B). We thus compared the phosphorylation of
SMAD2 and SMAD3 at their linker regions between
Map3k2/Map3k3Lck-Cre/ T cells and their WT counterparts.
T cell activation by anti-CD3 and anti-CD28 or with PMA and ion-
omycin treatment led to rapid and strong phosphorylation of
SMAD2 or SMAD3 at the linker regions in the WT T cells (Figures
4D and 4E). Such phosphorylation was severely impaired in the
Map3k2/Map3k3Lck-Cre/ T cells, indicating that MEKK2 and
MEKK3 are crucial for the TCR-induced phosphorylation of
SMAD2 and 3 at their linker regions.
To confirm that MEKK2 or MEKK3 were capable of inducing
R-SMAD linker region phosphorylation, and to verify that their
activation could suppress R-SMAD transcriptional activity, we
coexpressed Map3k2 or Map3k3 with SMAD3 in 293T cells.
Transient expression of either MEKK2 or MEKK3 was sufficient
to induce SMAD3 phosphorylation (Figure 4F) and SMAD2
(dada not shown) at the linker regions. Furthermore, expression
of either Map3k2 or Map3k3 was also able to inhibit the TGF-b-
induced CAGA12-Luc reporter activity (Figure 4G). Moreover,
the transcriptional activity of a mutant SMAD3, EPSM-SMAD3,
containing Ser or Thr to Ala or Val mutations in its linker region
(Calonge and Massague´, 1999) was more resistant than the
Figure 4. MEKK2 and MEKK3 Mediate
R-SMAD Linker Phosphorylation and Inhibit
SMAD Transcriptional Activity
(A) CAGA12-Luc plasmid was nucleofected into
WT or dKO CD4+ T cells. Four hours after nucleo-
fection, cells were stimulated with CD3+CD28
antibodies with or without TGF-b as indicated.
Luciferase activity was determined 16 hr
later and normalized to the activity of non-TGF-
b-stimulated cells.
(B) An illustration of known phosphorylation sites in
SMAD2 and SMAD3. MH1 and MH2, MAD
homology domain 1 and 2; linker, the sequence
that links MH1 and MH2 domains.
(C) WT or dKO CD4+ T cells were stimulated with
10 ng/ml TGF-b as indicated and the SMAD3
phosphorylation at the C terminus (Ser423/425)
was determined by immunoblotting. The ERK2
level is used as a loading control.
(D) WT or dKO CD4+ T cells were stimulated with
CD3+CD28 antibodies (Anti-CD3+28) for the indi-
cated time periods. Phosphorylation of the
SMAD2 and SMAD3 linker regions at SMAD2
Ser245+250+255, SMAD3 Ser204, SMAD2
Thr220, and SMAD3 Thr179 was determined by
immunoblotting. Total SMAD2 and SMAD3 protein
levels were determined by immunoblotting. Actin
level is shown as a loading control.
(E) WT and dKO CD4 T cells were stimulated
with PMA+ionomycin (PMA+Ion) for the indicated time periods. Phosphorylation of the SMAD2 linker region and total SMAD2 protein was determined
by immunoblotting.
(F) SMAD3 expression vector was cotransfected with either empty expression vector (Ctl) or expression vectors for Map3k2 (KK2) or Map3k3 (KK3) into 293T
cells. Twenty-four hours after transfection, phosphorylation of SMAD3 at the linker region was determined. ERK1 and 2 activation and expression of SMAD3,
MEKK2, and MEKK3 in the same transfection was determined by immunoblotting as indicated.
(G) CAGA12-Luc reporter plasmid was cotransfected into 293T cells with either empty expression vector (Ctl) or expression vectors for Map3k2 or Map3k3.
Twenty-four hours after transfection, cells were stimulated with the indicated concentrations of TGF-b for additional 12 hr. The reporter activity was determined
with a dual luciferase kit. The reporter activity without TGF-b stimulation was arbitrarily set as value 1 and used for normalization of the relative reporter activity.
Data shown are representative of three independent experiments. Error bars in (A) and (G) show standard deviation. **p < 0.01 by two-tailed Student’s t test.
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(Figure S3), further indicating that MEKK2 and 3 suppress the
R-SMAD activity at least in part through the linker region
phosphorylation.
ERK1 and ERK2 Mediate MEKK2- and MEKK3-
Dependent Phosphorylation of R-SMAD at Their Linker
Regions
Because MAPKs are known to phosphorylate R-SMAD at
the linker regions, it is possible that MEKK2 and 3 deficiency
may result in defective MAPK activation, which in turn leads to
the impaired R-SMAD phosphorylation. Indeed, we found
that activation of ERK1 and 2 and p38 MAPKs was severely
impaired in Map3k2/Map3k3Lck-Cre/ T cells as compared to
that in WT T cells after TCR stimulation (Figures 5A and 5B).
Consistent with the reduced activation of ERK1 and 2, induc-
tion of ERK1 and 2 target genes after TCR stimulation, such
as Egr1 and c-Fos, was greatly diminished in naive
Map3k2/Map3k3Lck-Cre/ T cells than that in WT T cells (Fig-
ure S4A). The JNK was marginally activated and appeared not
affected in the Map3k2/Map3k3Lck-Cre/ T cells (data not
shown).
Because both the ERK1 and 2 and p38 activation was
impaired in the Map3k2/Map3k3Lck-Cre/ T cells, we then
determined whether both of them or either one of them mightmediate the TCR-induced phosphorylation of R-SMAD at the
linker region. Inhibition of ERK1 and 2 but not p38 MAPK in WT
T cells greatly reduced the TCR-induced or PMA-induced phos-
phorylation of SMAD2 and SMAD3 at their linker regions (Figures
5C and 5D). Inhibition of both ERK1 and 2 and p38 did not further
reduce the SMAD linker region phosphorylation compared to
inhibition of ERK1 and 2, suggesting that there was no syner-
gistic effect between ERK1 and 2 and p38. Because other
kinases such as GSK3 and the CDKs are also able to phosphor-
ylate SMAD2 and 3 linker region under certain conditions
(Wrighton et al., 2009), to rule out their possible involvement in
this process, we treated WT T cells with either GSK3 inhibitor
(SB-216763) or CDK inhibitor (flavopiridol) and found that neither
of them was able to block the anti-CD3-induced SMAD linker
region phosphorylation (Figure S4B). Finally, although some
cytokines such as IL-2were able to induce ERK1 and 2 activation
in T cells, IL-2 did not induce R-SMAD linker region phosphory-
lation (Figure S4C). Thus, ERK1 and 2 are responsible for the
TCR-induced, MEKK2- and 3-dependent phosphorylation of
SMAD2 and 3 at the linker region.
To further examine the physiological significance of R-SMAD
linker region phosphorylation in T cells, we blocked the
R-SMAD linker region phosphorylation via inhibition of ERK1
and 2 and determined its effect on Treg cell differentiation. As
shown in Figure 5E, inhibition of ERK1 and 2 activation markedlyImmunity 34, 201–212, February 25, 2011 ª2011 Elsevier Inc. 207
Figure 5. ERK1 and 2Mediate the TCR-Induced SMAD Linker Region Phosphorylation and Inhibit the TGF-b Induced Treg Cell Differentiation
(A and B) WT or dKO CD4+ T cells were stimulated with CD3+CD28 antibodies (Anti-CD3+28) (A) or with PMA+ionomycin (PMA+Ion) (B) for the indicated time
periods. Phosphorylation of ERK1 and 2 and p38 was determined by immunoblotting. Total ERK2 protein level was shown as a loading control.
(C and D) WT CD4+ T cells were activated with a CD3 antibody (C) or with PMA treatment (D) in the presence of vehicle DMSO (Ctl), or MEK1/2 inhibitor U0126
(ERK-i), or p38 inhibitor SB203580 (p38-i), or both {(E+P)-i} as indicated. Phosphorylations of SMAD2 or SMAD3 at their linker regions and phosphorylation of
ERK1 and 2, and p38 at their activation loop, were determined by immunoblotting. ERK2 protein level was determined as a loading control. NT, nonstimulated
cells.
(E) WT naive CD4 T cells were differentiated into Treg cells with either no TGF-b or 1 ng/ml TGF-b in the presence of no inhibitor (Ctl), or MEK1 inhibitor (ERK-i), or
p38 inhibitor (p38-i), or both inhibitors (ERK-i+p38-i), as indicated. Foxp3+ Treg cells were determined 5 days later by flow cytometry as described in Figure 2.
Data presented are representative of three independent experiments.
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similar to that found in the Map3k2/Map3k3Lck-Cre/ T cells.
In contrast, inhibition of p38 activation had no effect on iTreg
cell differentiation. In addition, inhibition of both p38 and ERK1
and 2 did not further increase the iTreg cell differentiation
compared to ERK1 and 2 inhibition alone, further confirming
that the TCR-induced SMAD2 and 3 phosphorylation at the linker
region is mediated by ERK1 and 2, which negatively regulates
TGF-b signaling during Th cell differentiation.
SMAD3 Linker Region Phosphorylation Mutant Induces
More iTreg and Th17Cells thanWT SMAD3 inWT TCells
but Not in Map3k2–/–Map3k3Lck-Cre/– T Cells
To directly test the role of the linker region phosphorylation of
R-SMAD during Th cell differentiation, WT naive T cells were in-
fected with retroviruses that expressed either GFP alone, or GFP
plus WT SMAD3, or GFP plus EPSM-SMAD3, which is defective
in its linker region phosphorylation (Calonge and Massague´,
1999). The infected T cells were then differentiated into either
iTreg or Th17 cells in vitro. Expression of WT SMAD3 greatly
enhanced both iTreg and Th17 cell differentiation as compared
to the expression of the empty vector (Figure 6A). These results
confirmed previous findings that SMAD3 is required for iTreg cell208 Immunity 34, 201–212, February 25, 2011 ª2011 Elsevier Inc.differentiation and also suggested that SMAD3 was involved
in Th17 cell differentiation. Importantly, we found that EPSM-
SMAD3 hadmuch higher activity than theWTSMAD3 in inducing
either iTreg (93% versus 63%, respectively) or Th17 (41% versus
32%, respectively) cell differentiation (Figure 6A), indicating that
phosphorylation of SMAD3 at the linker region is inhibitory to
iTreg and Th17 cell differentiation.
If MEKK2 and 3 suppress the iTreg and Th17 cell differentiation
through the phosphorylation of R-SMAD at their linker regions,
we would predict that WT SMAD3 may have comparable
activity as the EPSM-SMAD3 in the Map3k2/Map3k3Lck-Cre/
T cells because the linker region of WT SMAD3 was hypophos-
phorylated in these cells (Figure 4D). Indeed, the WT SMAD3
induced similar Foxp3 expression as the EPSM-SMAD3 in the
Map3k2/Map3k3Lck-Cre/ T cells (Figure 6B, top). Consistent
with R-SMAD having elevated activity in the Map3k2/
Map3k3Lck-Cre/ T cells, WT SMAD3 also induced more Foxp3-
expressing cells from the Map3k2/Map3k3Lck-Cre/ T cells
(88%, Figure 6B) than from WT T cell (63%, Figure 6A) under
the same condition. Moreover, EPSM-SMAD3 induced similar
percentages of Foxp3-expressing cells from both the
Map3k2/Map3k3Lck-Cre/ T cells and WT T cells (Figures 6A
and 6B, top). Finally, WT SMAD3 and EPSM-SMAD3 also
Figure 6. MEKK2 and MEKK3 Regulate Treg and Th17 Cell Differen-
tiation through Mediating R-SMAD Linker Phosphorylation
WT (A) or dKO CD4+ T cells (B) were differentiated under the Treg or Th17
cell conditions, respectively, as described in Figure 2, except that the TGF-b
(1 ng/ml) was added at the 24 hr time point when the cells were infected
with empty retrovirus (GFP) or retroviruses that express WT-SMAD3 or
EPSM-SMAD3. The infection was repeated once at 36 hr. Five days later,
the infected cells were determined by GFP expression and analyzed for
Foxp3+ cells directly (top) or analyzed for IL-17A+ cells after restimulation
with PMA+ionomycin for 4 hr (bottom). The numbers in the graphs show the
percentages of gated populations. Data are representative of two independent
experiments.
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Map3k2/Map3k3Lck-Cre/ T cells (Figure 6B, bottom). Together
with the results from the above biochemical study, our data
strongly suggest that the TGF-b-dependent Th cell differentiation
is negatively controlled by a TCR-MEKK2 and 3-ERK1 and 2
MAPK module, which phosphorylates SMAD2 and SMAD3 at
their linker regions (Figure S5).Map3k2–/–Map3k3Lck-Cre/– Mice Have Enhanced Th17
Cell Response
To examine howMEKK2 and 3 deficiency in T cellsmay influence
effector CD4 T cell differentiation and impact the development of
acute inflammatory diseases, we used a well-characterized
mouse autoimmune disease model, the experimental
autoimmune encephalomyelitis (EAE) model. We immunized
Map3k2/Map3k3Lck-Cre/ mice with MOG35-55 peptide
and complete Freund’s adjuvant (CFA) and monitored the
development of EAE disease. Compared to WT mice, theMap3k2/Map3k3Lck-Cre/ mice developed more severe
disease after the immunization (Figure 7A) and recovered much
slower from the paralysis. Similar results were obtained with
the Rag1/ mice reconstituted with WT or Map3k2/
Map3k3Lck-Cre/ bone marrows (Figure 7B). Consistent with the
more severe disease, the Map3k2/Map3k3Lck-Cre/ mice had
more Th17 cells in both the central nervous system (CNS) and
the spleen compared to the WT mice, whereas the Th1 cells
appeared to be comparable (Figure 7C). Treg cells in the CNS
were slightly reduced in ratio in the Map3k2/Map3k3Lck-Cre/
mice, whereas their absolute numbers were comparable
(Figure 7D and data not shown). As in the nonimmunized
mice, the frequency of Foxp3+ Treg cells in the spleen of
Map3k2/Map3k3Lck-Cre/ mice remained higher than that in
the WT mice (Figure 7D).
To determine whether Map3k2/Map3k3Lck-Cre/ mice
produced more MOG-specific Th17 T cells, we tested the recall
response of WT and Map3k2/Map3k3Lck-Cre/ T cells after
in vivo MOG+CFA immunization. The antigen-induced produc-
tion of IL-17A by Map3k2/Map3k3Lck-Cre/ T cells was signifi-
cantly elevated over that by the WT T cells (Figure 7E), whereas
IFN-g production byMap3k2/Map3k3Lck-Cre/ T cells was also
reduced (Figure 7F). These data together indicate that the T cell-
specific deficiency ofMap3k2 andMap3k3 results in augmented
antigen-induced Th17 cell differentiation and consequent CNS
accumulation, leading to more severe EAE disease.
DISCUSSION
TGF-b is a central regulator of Th cell differentiation but the
underlying molecular mechanism by which the TGF-b signal is
regulated during Th cell differentiation is not fully understood.
Here we show that MEKK2 and MEKK3 deficiency in T cells
resulted in hypersensitivity to the TGF-b signaling during iTreg
and Th17 cell differentiation. We demonstrate that MEKK2 and
MEKK3 are essential for the TCR-mediated activation of ERK1
and 2 and p38 MAPKs. Further, Map3k2/Map3k3Lck-Cre/
mice develop more severe EAE disease and had more antigen-
specific Th17 cells that preferentially accumulate in the central
nervous system, suggesting that the MEKK2 and MEKK3
signaling pathway in T cells plays a crucial regulatory role in
inflammation and autoimmunity. This study thus unravels an
inhibitory mechanism that dampens the potential of TGF-
b response in Th cell differentiation and reveals a critical interplay
between the TCR-induced MAPK activation signal and the cyto-
kine-induced differentiation signals during Th cell differentiation.
MEKK2 and MEKK3 are two highly homologous MAP3Ks.
Although previous studies demonstrate that MEKK2 and
MEKK3 have nonoverlapping function in vivo, our current study
indicates that activation of either MEKK2 or MEKK3 alone is
sufficient to suppress the TGF-b responses in T cells. In addition,
either MEKK2 or MEKK3 is sufficient to activate ERK1 and ERK2
to phosphorylate SMAD2 or SMAD3 at their linker regions and to
suppress R-SMAD-dependent transcriptional activity. These
data indicate that MEKK2 and MEKK3 play overlapping roles in
regulating the TGF-b response through ERK1 and 2 in Th cell
differentiation.
Activation of ERK1 and 2 is mainly mediated by the Raf
subgroup of MAP3Ks in T cells and other cell types. OtherImmunity 34, 201–212, February 25, 2011 ª2011 Elsevier Inc. 209
Figure 7. Map3k2–/–Map3k3Lck-Cre/– Mice
Exhibit More Severe EAEDisease and Accu-
mulate More Th17 Cells in the Acute Inflam-
matory Response
(A) WT (n = 5) and dKO (n = 4) mice were immu-
nized with MOG35-55+CFA plus pertussis toxin to
induce EAE disease. The immunized mice were
observed for the indicated length of time and the
mean clinical scores for the severity of EAE were
determined.
(B) Sublethally irradiated Rag1/ mice were re-
constituted with either dKO (n = 4) or WT (n = 5)
bonemarrow cells. Tenweeks after the reconstitu-
tion, EAE disease was induced and analyzed as
described in (A).
Data shown are representative of two independent
experiments. Error bars show standard error of the
mean. **p < 0.01, *p < 0.05, by two-tailed
Student’s t test.
(C and D) EAE disease was induced in WT or dKO
mice as described in (A). Twenty-eight days after
the immunization, CD4+ T cells were gated from
the total leukocytes in the central nervous system
(CNS) or spleen (SPL) and further analyzed for
frequencies of IL-17A+ and IFN-g+ cells (C) and
Foxp3+ cells (D) by flow cytometry. The numbers
in the plots indicate the percentages of the gated
populations. Data shown are representative of
three independent experiments.
(E and F) On day 8 after MOG+CFA immunization,
WT or dKO splenocytes were restimulated with
indicated concentrations of MOG peptide
in vitro. The production of IL-17A (E) and IFN-g
(F) in culture supernatants was determined
3 days later by ELISA. Data shown are average
values of triplicates. Error bars show standard
deviation. The results are representative of four
mice of each genotype from two independent
experiments. **p < 0.01 by two-tailed Student’s
t test.
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MAPK Limits TGF-b Responses in Developing Th CellsMAP3Ks such as MEKK1 (Yujiri et al., 1998), MEKK2 (Zhang
et al., 2006), MEKK3 (Kim et al., 2007), and Tpl2 (Jager et al.,
2010) are also implicated in ERK1 and 2 activation in T cells
and other cell types either directly or indirectly. It is conceivable
that these various alternative ERK1 and 2 activation pathways
could allow cells to use the ubiquitous ERK1 and 2 MAPK
module to selectively respond to distinct extracellular stimuli
under different conditions. The specific MEKK2 and 3-ERK1
and 2 module in T cells may be one of such examples that is
involved in transducing specifically the TCR signals to regulate
the TGF-b pathway without affecting the Raf-ERK1 and 2-
mediated growth signals during Th cell differentiation. Consis-
tently, activation of ERK1 and 2 by cytokines such as IL-2 in
T cells did not induce R-SMAD linker region phosphorylation,
Therefore, our work suggests an interesting model that the
TGF-b-dependent Th cell differentiation is negatively controlled
by a TCR-MEKK2 and 3-ERK1 and 2 MAPK module, which
phosphorylates SMAD2 and SMAD3 at their linker regions.
The NF-kB pathway has been reported to play a positive role
in Treg cell differentiation (Long et al., 2009; Ruan et al., 2009).
We previously showed that MEKK3 plays a role in NF-kB
activation by the TLR ligands and proinflammatory cytokines210 Immunity 34, 201–212, February 25, 2011 ª2011 Elsevier Inc.in fibroblasts (Huang et al., 2004; Yang et al., 2001). However,
we did not find obvious augmentation of NF-kB activation
in Map3k2/Map3k3Lck-Cre/ T cells, indicating that the
augmented iTreg cell differentiation from naive Map3k2/
Map3k3Lck-Cre/ T cells was probably not due to the altered
NF-kB pathway. Although studies from another group reported
that MEKK3 was required for NF-kB activation in T cells
(Shinohara et al., 2009), we found no obvious defect in the
TCR-induced IKKb activation and IkBa degradation in either
Map3k3Lck-Cre/ or Map3k2/Map3k3Lck-Cre/ T cells (data not
shown). Interestingly, the induction of p65 phosphorylation at
Ser534 after TCR stimulation was impaired in Map3k2/
Map3k3Lck-Cre/ T cells, supporting a role of MEKK2 and
MEKK3 in NF-kB pathway activation in T cells (data not shown).
Nevertheless, we believe that this defect is most probably
unrelated to the increased Treg cell differentiation of
Map3k2/Map3k3Lck-Cre/ T cells because defective NF-kB
activation should inhibit but not augment the Treg cell differenti-
ation (Long et al., 2009; Ruan et al., 2009).
The peripheral T cells in the Map3k2/Map3k3Lck-Cre/ mice
appeared to be overtly activated, but the cause of this change
is unclear. However, this is probably not the reason why the
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MAPK Limits TGF-b Responses in Developing Th CellsMap3k2/Map3k3Lck-Cre/ T cells are hypersensitive to TGF-b
signal because naive peripheral T cells or thymic CD4 SP
T cells that have not been previously activated were also hyper-
sensitive to TGF-b signal. Interestingly, although the frequencies
of iTreg cells were increased in the Map3k2/Map3k3Lck-Cre/
mice and they were able to suppress naive T cell proliferation
in vitro, they failed to suppress the activated T cell phenotype
in the Map3k2/Map3k3Lck-Cre/ mice. Similarly, the Treg
cells in the Map3k2/Map3k3Lck-Cre/ mice failed to suppress
the pathogenesis of EAE. In this regard, expansion of iTreg cells
has been frequently observed in autoinflammatory conditions
such as in the CNS of a mouse EAE model (Korn et al., 2007)
or in the inflamed joints of rheumatoid arthritis patients (Ruprecht
et al., 2005). One possible cause of this phenomenon could be
the overproduction of IL-6 induced by IL-17A in the
Map3k2/Map3k3Lck-Cre/ mice, which has been shown to
dampen the iTreg cell-mediated suppression of naive T cell acti-
vation (Pasare and Medzhitov, 2003).
Finally, the augmented T cell activation and the increased
Th17 cells in the periphery may predispose the Map3k2/
Map3k3Lck-Cre/ mice to autoimmune diseases. However, no
spontaneous autoimmune syndromes have been observed in
Map3k2/Map3k3Lck-Cre/ mice up to 15 months old. In
contrast, under acute inflammatory condition, after immuniza-
tion with MOG+CFA, the Map3k2/Map3k3Lck-Cre/ mice
suffered more severe disease than the WT mice, which is
most probably caused by the enhanced production of MOG-
specific Th17 cells and their CNS accumulation. It is therefore
possible that MEKK2 and MEKK3 may positively affect immune
tolerance dependent on the inflammatory status, similar to
the role of TGF-b in autoimmune diseases. Interestingly,
similar to our observation, mice with ERK1 deficiency also
had more severe EAE disease after the MOG/CFA immuniza-
tion (Agrawal et al., 2006). Future studies of the roles of
MEKK2 and MEKK3 in immune tolerance and autoimmunity
will be rewarding.EXPERIMENTAL PROCEDURES
Mice
Mekk3 germline KO mice,Map3k3fl/fl mice,MAP3k3 T cell conditional-deleted
mice, andMap3k2/mice were described before and were bred with C57BL/
6mice formore than 10 generations (Cheng et al., 2000; Guo et al., 2002;Wang
et al., 2009). Lck-Cre transgenic mice in C57BL/6 background, C57BL/6
Rag1/, WT C57BL/6 mice, and C57BL/6 CD45.1 (B6.SJL) congenic mice
were obtained from the Jackson Laboratory. All mice were maintained under
pathogen-free conditions. Unless indicated, all mice were used between 10
and 15 weeks old. All animal experimentation was conducted in accordance
with institutional guidelines.
Bone Marrow Transplantation
Bone marrow cells were isolated from Map3k2/Map3k3Lck-Cre/ mice, WT
mice, or B6.SJL mice. Five million cells were injected intravenously into
Rag1/ mice, which received a sublethal irradiation (400 rad) 1 day before.
Chimeric mice were analyzed 6 to 8 weeks after transplantation.
Chemical Inhibitors
The following inhibitors were used: MEK inhibitor (PD98059, 5 mM), MEK1/2
inhibitor (U0126, 5 mM), p38 inhibitor (SB20190, 5 mM), CDK inhibitor (flavopir-
idol, 0.3 mM), GSK3a/b inhibitor (SB-216763, 5 mM), and TGF-bR inhibitor
(SB431542). All inhibitors were obtained from Sigma.ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE26987.
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Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at doi:10.
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